Our Consultants

Powerful Team For Success

Our Team of Consultants

Our business model utilizes consultants on an “as needed” basis. This keeps overhead / “burn rate” extremely low.

Brian Peskin

Brian Peskin – BSEE, MIT (1979)

  • Founder of Peskin Pharmaceuticals
  • Theoretical research scientist specializing in lipids-based pharmacognosy; class of drug derived from plants
  • > 25 years of specialization / research / lecturing in this field
  • Multiple books and articles on EFAs and their and long-chain eicosanoid roles in human diseases
  • Translation science expertise in underlying pathophysiology of inflammation Hypertension / CAC

Responsible for commercial development of PSK003

Selected KEY PARTNERS as needed in the FDA Phase 2 (IIb) of PSK003

Dr. Geoffrey L. Robb

Geoffrey Robb, MD

  • Contract as needed Medical Director
  • Former Chairman of MD Anderson’s Dept. of Plastic and Reconstructive Surgery for over 15 years.
  • As a microsurgeon, high appreciation of low CAC and maximum vascular function
  • Excellent physiological and biochemical understanding of PSK003.
  • Over 60 invited articles including editorials, and over 50 abstracts, 27 book chapters and 15 books.

Responsible for Medical Affairs

Physician-sponsored FDA Phase 2 proof-of-concept trial:

Ray Kurker, MD: South Windsor, CT

  • Physician-Sponsored trial leader

Responsible for Clinical Trial Project Management

Powerful Clinical Team For Success

Additional staff contracted as required, including:

Cardiology: Prof. Peter U. Feig, MD

Merck

Senior Director, Cardiovascular Clinical Research (2004-2011)

Bayer

International Project Manager, Worldwide Diabetes Program (1993-1997)
Acting Director, Cardiovascular Medical Research (1991-1993)
Associate Director, Cardiovascular Medical Research (1989-1991)

“End-to-end” coordination from basic science to commercialization / in-licensing / collaborative partnerships with other pharmaceutical companies. Consultant to pharma VCs.

Imaging Specialists

Medical Metrics performs 3rd party independent analysis of all CT scans for CAC. Extensive expertise in coronary artery disease and have supported more than three dozen regulatory approvals.

CRO: International Healthcare Contract Research Organization

Uniquely, IHC has extensive internal support personnel to minimize our staffing / overhead. Highly experienced CRO with expertise in FDA cardiology trials. They perform all project management — administrative personnel / implementing & conducting all aspects of the clinical trial, of course, including obtaining sites and enrolling patients.

FDA Liaison / Medical Writing: Palo Verde Clinical Research

Highly experienced FDA liaison (all FDA submissions) / medical writing specialist.

Statistics: Statistics Consult

Alexander Kiss, PhD – biostatistics / Specialist in biostatistics with over 200 co-authored articles, including the American Journal of Hypertension and Circulation. A statistical consultant to a division of the National Institutes of Health (NIH). Head of the Department of Research Design and Biostatistics at one of Canada's largest hospitals. 15 years of experience teaching a variety of statistics and biostatistics courses to university students at 3 different universities.

Miscellaneous

CFO: Stephen Peskin, CPA: Extensive contract CFO experience.